RTW Biotech Opportunities Ltd (RTW) ORD NPV
- Add to watchlist
- Create an alert
- This stock can be held in a
News, reports & tips
No news items about RTW Biotech Opportunities Ltd ORD NPV were found.
Company announcements Announcements
-
New Investment in Series A of Ottimo Pharma
20 December 2024 12:15
RTW Biotech Opportunities Ltd
-
Monthly Valuation Update and Factsheet
13 December 2024 07:00
RTW Biotech Opportunities Ltd
-
Holding(s) in Company
10 December 2024 12:00
RTW Biotech Opportunities Ltd
-
Appointment of Senior Independent Director
10 December 2024 07:00
RTW Biotech Opportunities Ltd
-
CORXEL Announces Acceptance of NDA for Aficamten
15 November 2024 07:00
RTW Biotech Opportunities Ltd
-
Monthly Valuation Update and Factsheet
14 November 2024 07:00
RTW Biotech Opportunities Ltd
-
RTW Biotech Opportunities’ 5th Anniversary
1 November 2024 07:00
RTW Biotech Opportunities Ltd
-
Monthly Valuation Update and Factsheet Replacement
14 October 2024 18:12
RTW Biotech Opportunities Ltd
-
Launch of Obesity Company Kailera Therapeutics
3 October 2024 07:00
RTW Biotech Opportunities Ltd
-
New Investment in Aktis Oncology
2 October 2024 07:00
RTW Biotech Opportunities Ltd
-
BioAge Labs completes $198 million IPO
27 September 2024 07:00
RTW Biotech Opportunities Ltd
-
GBP quote for the share class to cease
26 September 2024 07:00
RTW Biotech Opportunities Ltd
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.